Differential signaling of FGFR1 and FGFR2 has previously been investigated in mammary epithelial cells and prostate cancer cells using drug-inducible systems, in which FGFR1 and FGFR2 can be expressed and activated at the same level [37], [38]. The gene discussed is FGFR2; the disease is prostate carcinoma.